Liquid Biopsy Research Reveals New Insights on Genetic Changes in Cancer
Researchers used Menarini Silicon Biosystems’ liquid biopsy technology to learn more about genetic changes in circulating cancer cells.
Read MorePosted by Melanie Hamilton-Basich | Aug 7, 2020 | Breast, Molecular Diagnostics |
Researchers used Menarini Silicon Biosystems’ liquid biopsy technology to learn more about genetic changes in circulating cancer cells.
Read MorePosted by Melanie Hamilton-Basich | Jul 29, 2020 | Lung Cancer, Molecular Diagnostics |
Israeli laboratories are approved to use molecular profiling assays for NSCLC patients using Thermo Fisher Scientific’s Oncomine Comprehensive Assay Plus.
Read MorePosted by Melanie Hamilton-Basich | Jul 23, 2020 | Molecular Diagnostics, Pancreatic, Unknown Origin & Other Cancer Types |
Caris will provide DNA and RNA molecular testing to support patient identification and enrollment for Merus’ Zenocutuzumab Phase 1/2 eNRGy trial.
Read MorePosted by Laurie Bonner | Jul 10, 2020 | Company News, Lung Cancer |
The collaborators are pursuing regulatory approval of the Guardant360 CDx as a companion diagnostic for amivantamab for the treatment of NSCLC.
Read MorePosted by Laurie Bonner | Jul 4, 2020 | Infectious Diseases |
A new identification reagent speeds diagnoses of chickenpox and shingles.
Read More